{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:43:53Z","timestamp":1792986233841,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.radonc.2016.11.008","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T00:07:32Z","timestamp":1480464452000},"page":"364-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":133,"title":["HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)"],"prefix":"10.1016","volume":"121","author":[{"given":"Annett","family":"Linge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Lohaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"L\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Gudziol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e4re","family":"von Neubeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"J\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Tinhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Budach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stuschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Balermpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca-Ligia","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Ganswindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Belka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi","family":"Pigorsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"M\u00f6nnich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela E.","family":"Aust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo B.","family":"Baretton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard D.","family":"Thames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dubrovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Alsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mechthild","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2016.11.008_b0005","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2016.11.008_b0010","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1200\/JCO.1993.11.11.2136","article-title":"Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study","volume":"11","author":"Adelstein","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0020","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1200\/JCO.2004.12.193","article-title":"Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy","volume":"22","author":"Huguenin","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2016.11.008_b0030","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1200\/JCO.2006.06.1291","article-title":"Clinical implications of human papillomavirus in head and neck cancers","volume":"24","author":"Fakhry","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9","article-title":"Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma","volume":"92","author":"Lindel","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.11.008_b0040","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00066-014-0801-3","article-title":"High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma","volume":"191","author":"Tehrany","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.11.008_b0045","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1200\/JCO.2008.20.2853","article-title":"Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck","volume":"27","author":"Lassen","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.radonc.2011.02.010","article-title":"The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial","volume":"100","author":"Lassen","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2014.11.011","volume":"113","author":"Lohaus","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0060","first-page":"255","article-title":"HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC","volume":"3","author":"Lohaus","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.radonc.2016.11.008_b0065","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1158\/1078-0432.CCR-15-1990","article-title":"Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV(\u2212) HNSCC after postoperative radiochemotherapy: a multicenter study of the DKTK-ROG","volume":"22","author":"Linge","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2016.11.008_b0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.radonc.2014.10.001","article-title":"Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets","volume":"113","author":"Skripcak","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0075","series-title":"Tomography, data processing and image reconstruction for medicine and engineering","first-page":"8","article-title":"A modular Software system for Image Analysis in Positron Emission Tomography Abstract book of the 2012 Workshop","author":"Haase","year":"2012"},{"key":"10.1016\/j.radonc.2016.11.008_b0080","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-11-1182","article-title":"Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer","volume":"71","author":"Toustrup","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2016.11.008_b0085","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1158\/1078-0432.CCR-13-0542","article-title":"A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer","volume":"19","author":"Eustace","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2016.11.008_b0090","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrg2665","article-title":"Generating specificity and diversity in the transcriptional response to hypoxia","volume":"10","author":"Lendahl","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.radonc.2016.11.008_b0095","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","article-title":"Evolution of the cancer stem cell model","volume":"14","author":"Kreso","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.radonc.2016.11.008_b0100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.radonc.2013.03.013","article-title":"HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity","volume":"107","author":"Rieckmann","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0105","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1158\/0008-5472.CAN-13-0587","article-title":"Enhanced radiation sensitivity in HPV-positive head and neck cancer","volume":"73","author":"Kimple","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2016.11.008_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctro.2016.10.002","article-title":"Independent validation of the prognostic value of CSC marker expression and hypoxia-induced gene expression of HNSCC after postoperative radiotherapy","author":"Linge","year":"2016","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0115","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1158\/1078-0432.CCR-10-0799","article-title":"CD44 expression predicts local recurrence after radiotherapy in larynx cancer","volume":"16","author":"de Jong","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2016.11.008_b0120","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2013.11.010","article-title":"Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer","volume":"50","author":"Rietbergen","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2016.11.008_b0125","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ijrobp.2016.01.005","article-title":"Radiation-induced dedifferentiation of head and neck cancer cells into cancer stem cells depends on human papillomavirus status","volume":"94","author":"Vlashi","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.11.008_b0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0167-8140(97)00215-6","article-title":"Tumor volume: a basic and specific response predictor in radiotherapy","volume":"47","author":"Dubben","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0135","article-title":"Cancer stem cells: radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments","author":"Krause","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.radonc.2016.11.008_b0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.radonc.2012.12.008","article-title":"GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: subgroup analysis of the prospective randomized CHARTWEL trial","volume":"106","author":"Soliman","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2307\/3577740","article-title":"Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units","volume":"123","author":"Baumann","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2016.11.008_b0150","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrc2419","article-title":"Exploring the role of cancer stem cells in radioresistance","volume":"8","author":"Baumann","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2016.11.008_b0155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0360-3016(96)00242-8","article-title":"Tumor volume and local control probability: clinical data and radiobiological interpretations","volume":"36","author":"Bentzen","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.11.008_b0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0360-3016(95)00119-J","article-title":"The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography","volume":"33","author":"Johnson","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.11.008_b0165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0167-8140(95)01539-S","article-title":"The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors","volume":"35","author":"van den Bogaert","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0170","first-page":"1363","article-title":"Impact of primary tumor volume on local control after definitive radiotherapy for head and neck cancer","volume":"36","author":"Mendenhall","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.11.008_b0175","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00066-013-0413-3","article-title":"Volumetric stratification of cT4 stage head and neck cancer","volume":"189","author":"Studer","year":"2013","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.11.008_b0180","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00066-014-0603-7","article-title":"Impact of initial tumor volume on radiotherapy outcome in patients with T2 glottic cancer","volume":"190","author":"Rutkowski","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.11.008_b0185","first-page":"429","article-title":"The effect of tumor volume on radiotherapy outcome and correlation with other prognostic factors in patients with T2 supraglottic cancer","volume":"18","author":"Rutkowski","year":"2014","journal-title":"Contemp Oncol (Pozn)"},{"key":"10.1016\/j.radonc.2016.11.008_b0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.radonc.2007.04.001","article-title":"Tumor progression in waiting time for radiotherapy in head and neck cancer","volume":"84","author":"Jensen","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2005.06.038","article-title":"Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study","volume":"77","author":"Nordsmark","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0200","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00066-011-2210-1","article-title":"Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control","volume":"187","author":"Zips","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.11.008_b0205","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.radonc.2010.04.020","article-title":"Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation","volume":"96","author":"Yaromina","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0167-8140(96)91811-3","article-title":"Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck","volume":"41","author":"Nordsmark","year":"1996","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0215","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1093\/jrr\/rrw007","article-title":"The impact of hypoxia and its modification of the outcome of radiotherapy","volume":"57","author":"Horsman","year":"2016","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2016.11.008_b0220","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1259\/0007-1285-26-312-638","article-title":"The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy","volume":"26","author":"Gray","year":"1953","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2016.11.008_b0225","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2007.12.7878","article-title":"Hypoxic radiosensitization: adored and ignored","volume":"25","author":"Overgaard","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0230","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3109\/09553002.2014.916841","article-title":"Hypoxia as a biomarker for radioresistant cancer stem cells","volume":"90","author":"Peitzsch","year":"2014","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2016.11.008_b0235","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.molonc.2012.01.007","article-title":"Individualization of cancer treatment from radiotherapy perspective","volume":"6","author":"Yaromina","year":"2012","journal-title":"Mol Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0240","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2011.09.010","article-title":"Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck","volume":"102","author":"Toustrup","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.11.008_b0245","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1158\/0008-5472.CAN-06-3322","article-title":"Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers","volume":"67","author":"Winter","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2016.11.008_b0250","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1158\/1078-0432.CCR-10-2244","article-title":"CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy","volume":"16","author":"Baumann","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2016.11.008_b0255","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1158\/1078-0432.CCR-16-0069","article-title":"Improving the predictive value of preclinical studies in support of radiotherapy clinical trials","volume":"22","author":"Coleman","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2016.11.008_b0260","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijrobp.2015.11.019","article-title":"Impact of expression of CD44, a cancer stem cell marker, on the treatment outcomes of intensity modulated radiation therapy in patients with oropharyngeal squamous cell carcinoma","volume":"94","author":"Motegi","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.11.008_b0265","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/cncr.26485","article-title":"Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial","volume":"118","author":"Wu","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.11.008_b0270","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/hed.23493","article-title":"Indications for postoperative radiotherapy in laryngeal carcinoma: a panel of tumor tissue markers for predicting locoregional recurrence in surgically treated carcinoma. A pilot study","volume":"36","author":"Marioni","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.11.008_b0275","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.29683","article-title":"CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)","volume":"138","author":"Balermpas","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2016.11.008_b0280","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejca.2016.01.003","article-title":"Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation","volume":"57","author":"Tinhofer","year":"2016","journal-title":"Eur J Cancer"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016343833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016343833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T12:42:51Z","timestamp":1530103371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814016343833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0167814016343833"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2016.11.008","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2016.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}